Previous close | 1,152.00 |
Open | 1,146.50 |
Bid | 1,131.50 x 0 |
Ask | 1,132.50 x 0 |
Day's range | 1,122.00 - 1,147.64 |
52-week range | 959.20 - 1,338.50 |
Volume | |
Avg. volume | 2,819,156 |
Market cap | 9.891B |
Beta (5Y monthly) | 0.35 |
PE ratio (TTM) | 53.93 |
EPS (TTM) | 0.21 |
Earnings date | 21 Feb 2023 |
Forward dividend & yield | 0.32 (2.76%) |
Ex-dividend date | 30 Mar 2023 |
1y target est | 13.68 |
Smith & Nephew (SNN) achieves a positive response for its COBLATION-Technology-infused Intracapsular Tonsillectomy Technique, providing fast patient recovery over existing surgeries.
Smith & Nephew (SNN) introduces QUADTRAC System and broadens ULTRABUTTON Adjustable Fixation Devices portfolio for ACL reconstruction.
Most readers would already know that Smith & Nephew's (LON:SN.) stock increased by 9.9% over the past three months...